Virtual Disaster Medicine

Training Center (VDMTC)

Module 14

Advanced Airway Techniques

Part 2 - New Generation Supraglottic Ventilatory Devices>

Desirable Features and Optimal Methods for Testing

 

 

ISSUES

 

Until the late 1980’s, the options for maintaining the airway during anesthesia were largely limited to the ET, or the facemask combined with an oropharyngeal airway.  The initial response was sceptical but despite this, many ‘gave it a go’ and it was soon firmly established in anesthetic practice.  Since then the LMA (now called the LMA-ClassicTM, cLMA) has been used in approximately 150 million anesthetics and there are over 2400 studies published on the use of the device.

 

The market for supraglottic airways is extensive.  Recent surveys in three European Countries have reported that the cLMA is used in approximately 65% of general anesthetics.  In the UK this represents 3.5 million uses each year.  At approximately $3 per use, this market costs in excess of $12 million per year, in the UK.  Of course, the UK represents only a fraction of the global market.

 

There are five variations of the laryngeal mask (classic, flexible, intubating, double-lumen and disposable) and at least 10 other distinct supraglottic airways currently on the market.  Two more are in final development (AMD, GPT- glossopharyngeal tube).  Two had been introduced and have now been abandoned (COPA- cuffed oropharyngeal airway, The glottic aperture airway (GO2; Augustine Medical, Inc., Eden Praire, MN) actually never made it into clinical use.  Mallinckrodt, Hazelwood, MO; PAx - Pharyngeal Airway Express, Vital Signs, Totowa, NJ).

 

The market for single-use devices is increasing.  There are five different manufacturers of single use cLMAs (Ambu, Intavent Orthofix [probably LMA company for North America], Intersurgical, Marshalls and Portex), at the time of writing, and this is expected to increase to twelve within a year.  There are important design differences between all five single use cLMAs.  If all variants are included, there are 19 supraglottic airways available for non-intubated patients and nine more soon to be released.  All but three of these devices have been introduced to Europe in the last three years.

 

 

go to page      previous    1  2  3  4  5  6  7    next